Comorbidity in bipolar disorder: a framework for rational treatment selection

Area of Science:

• Psychiatry
• Pharmacology
• Neuroscience

Background:

• Bipolar disorders are complex and heterogeneous, often necessitating multifaceted treatment approaches.
• The growing number of available medications for bipolar disorder highlights the need for a structured treatment framework.
• No single medication effectively manages the full spectrum of bipolar disorder symptoms.

Purpose of the Study:

• To address the need for a treatment framework for bipolar disorder that accounts for its multidimensionality and common comorbidities.
• To propose an organizational schema for managing bipolar disorder, considering the efficacy of various mood stabilizers and comorbid conditions.

Main Methods:

• Review of existing literature on monotherapy and polypharmacotherapy for bipolar disorder.
• Analysis of treatment data for established and putative mood stabilizers.
• Consideration of treatment data for comorbid and accessory conditions in bipolar disorder.

Main Results:

• Rigorous trials indicate monotherapy efficacy for specific bipolar disorder phases, yet polypharmacotherapy is common in clinical practice.
• The evidence base for polypharmacotherapy in bipolar disorder is currently limited but is an active area of research.
• Existing neurotherapeutic agents are not singularly effective for the entire range of bipolar symptomatology.

Conclusions:

• A treatment framework for bipolar disorder is needed to guide clinicians in managing complex cases.
• The proposed schema aims to organize treatment strategies by considering mood stabilizer effectiveness and comorbid conditions.
• Further research is encouraged to develop and validate treatment schemas for bipolar disorder management.